Effect of Vitamin D2 on Adipokines in Obese Type 2 Diabetic Patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800014359

Enrollment

Unknown

Registered

2018-01-08

Start date

2018-01-01

Completion date

Unknown

Last updated

2018-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

treatment group:vitamin D2 60,0000 u injection q2w

control group:blank

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed as type 2 diabetes patients, aged 30-70 years old; 2. BMI> = 28kg/m^2; 3. Serum 25 (OH) D levels below 20ng/ml; 4. All patients signed informed consent, voluntarily participate, and can accept the relevant inspection.

Exclusion criteria

Exclusion criteria: 1. allergic to vitamin D preparations; 2. BMI <28kg / m2; 3. Diabetic ketoacidosis or hyperglycemia in high glucose; 4. Infection, poisoning, cancer, metabolism and other diseases; 5. Severe chronic complications of diabetes,or severe liver/kidney dysfunction, cardiac dysfunction in patients.

Design outcomes

Primary

Measure	Time frame
body weight;leptin;adopnectin;visfatin;nesfatin-1;Waist circumference;	—

Countries

China

Contacts

Public ContactChen Ruihua

Shanghai New Area People's Hospital

mizuno@yeah.net+86 18917901822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026